Valid for Submission
C69.50 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of unspecified lacrimal gland and duct. The code C69.50 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code C69.50 might also be used to specify conditions or terms like adenocarcinoma of lacrimal gland, adenoid cystic carcinoma of lacrimal gland, carcinoma ex pleomorphic adenoma of lacrimal gland, lump in caruncle of eye, malignant melanoma of lacrimal drainage system , malignant melanoma of lacrimal gland, etc.
Unspecified diagnosis codes like C69.50 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adenocarcinoma of lacrimal gland
- Adenoid cystic carcinoma of lacrimal gland
- Carcinoma ex pleomorphic adenoma of lacrimal gland
- Lump in caruncle of eye
- Malignant melanoma of lacrimal drainage system
- Malignant melanoma of lacrimal gland
- Malignant neoplasm of lacrimal sac
- Malignant neoplasm of nasolacrimal duct
- Malignant tumor of conjunctiva
- Malignant tumor of lacrimal drainage structure
- Malignant tumor of lacrimal gland
- Mucoepidermoid tumor of lacrimal gland
- Neoplasm of nasolacrimal duct
- Primary adenocarcinoma of lacrimal apparatus
- Primary adenocarcinoma of lacrimal gland
- Primary malignant neoplasm of lacrimal apparatus
- Primary malignant neoplasm of lacrimal caruncle
- Primary malignant neoplasm of lacrimal drainage system
- Primary malignant neoplasm of lacrimal gland
- Primary malignant neoplasm of lacrimal gland duct
- Primary malignant neoplasm of orbit
- Primary mucoepidermoid carcinoma of lacrimal apparatus
- Primary squamous cell carcinoma of lacrimal apparatus
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|124||OTHER DISORDERS OF THE EYE WITH MCC||02||1.3988|
|125||OTHER DISORDERS OF THE EYE WITHOUT MCC||02||0.8354|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert C69.50 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code C69.50 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up of muscles, skin and nerves. If the cancer starts inside the eyeball it's called intraocular cancer. The most common intraocular cancers in adults are melanoma and lymphoma. The most common eye cancer in children is retinoblastoma, which starts in the cells of the retina. Cancer can also spread to the eye from other parts of the body.
Treatment for eye cancer varies by the type and by how advanced it is. It may include surgery, radiation therapy, freezing or heat therapy, or laser therapy.
[Learn More in MedlinePlus]